Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

Cutaneous PTCL-NOS (CD8+ or CD56+ and Cytotoxic Marker)

Tundra lists 1 Cutaneous PTCL-NOS (CD8+ or CD56+ and Cytotoxic Marker) clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT05475925

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

This is a multicenter, first-in-human, Phase 1/2 study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and anti-tumor activity of DR-01 in adult patients with large granular lymphocytic leukemia or cytotoxic lymphomas

Gender: All

Ages: 18 Years - Any

Updated: 2026-03-05

13 states

LGLL - Large Granular Lymphocytic Leukemia

Primary Cutaneous Gamma-Delta T-Cell Lymphoma

Primary Cutaneous CD8+ Aggressive Epidermotropic T-Cell Lymphoma

+10